ValuEngine Downgrades IBM (IBM) to Sell
Several other research firms have also recently issued reports on IBM. UBS Group set a $160.00 price target on IBM and gave the company a “buy” rating in a report on Wednesday. Wedbush reaffirmed a “hold” rating and issued a $131.00 price target on shares of IBM in a report on Wednesday, January 23rd. BMO Capital Markets upped their price target on IBM to $147.00 and gave the company a “market perform” rating in a report on Wednesday, January 23rd. They noted that the move was a valuation call. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $140.00 price target on shares of IBM in a report on Wednesday, January 16th. Finally, Stifel Nicolaus upped their price target on IBM from $145.00 to $178.00 and gave the company a “buy” rating in a report on Tuesday, January 15th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and seven have issued a buy rating to the stock. IBM has a consensus rating of “Hold” and a consensus price target of $155.72.
Shares of NYSE:IBM opened at $140.33 on Thursday. IBM has a 12 month low of $105.94 and a 12 month high of $154.36. The company has a market cap of $124.87 billion, a P/E ratio of 10.16, a PEG ratio of 2.55 and a beta of 1.25. The company has a current ratio of 1.29, a quick ratio of 1.24 and a debt-to-equity ratio of 2.10.
In other IBM news, insider Diane J. Gherson sold 1,989 shares of IBM stock in a transaction that occurred on Wednesday, February 13th. The shares were sold at an average price of $137.25, for a total transaction of $272,990.25. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Erich Clementi sold 13,000 shares of IBM stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $139.01, for a total transaction of $1,807,130.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 20,867 shares of company stock worth $2,877,569. Corporate insiders own 0.19% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Nalls Sherbakoff Group LLC purchased a new position in IBM during the 4th quarter worth approximately $34,000. Sycomore Asset Management purchased a new position in shares of IBM during the 4th quarter valued at $81,000. Sharkey Howes & Javer grew its holdings in shares of IBM by 75.9% during the 4th quarter. Sharkey Howes & Javer now owns 721 shares of the technology company’s stock valued at $82,000 after acquiring an additional 311 shares in the last quarter. Sonora Investment Management LLC grew its holdings in shares of IBM by 166.2% during the 4th quarter. Sonora Investment Management LLC now owns 1,637 shares of the technology company’s stock valued at $186,000 after acquiring an additional 1,022 shares in the last quarter. Finally, Paloma Partners Management Co grew its holdings in shares of IBM by 127.4% during the 3rd quarter. Paloma Partners Management Co now owns 1,453 shares of the technology company’s stock valued at $220,000 after acquiring an additional 6,757 shares in the last quarter. Hedge funds and other institutional investors own 55.58% of the company’s stock.
IBM Company Profile
International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers a portfolio of enterprise artificial intelligence platforms, such as analytics and data management platforms, cloud data services, talent management, and industry solutions primarily under the Watson Platform, Watson Health, and Watson Internet of Things names.
Featured Article: Leveraged Buyout (LBO)
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.